Skip to main content

Table 2 Identification of risk factors for LTBI among HIV positive

From: Latent Tuberculosis in HIV positive, diagnosed by the M. Tuberculosis Specific Interferon-γ test

 

QTF negative (n = 543)

QTF positive (n = 27)

OR, (95% CI)

P values

Age, median years (25th–75th quartile)

43 (38–50)

42 (36–49)

 

P = 0.05

Male sex, no (%)

405 (75)

17 (63)

  

Tuberculosis

    

Previous TB diagnosis no. (%)

22 (4)

5 (19)

4.9 (1.7–14.1)

p= 0.0063

Tuberculosis risk factors, no. (%)

    

   History of exposure

43 (8)

8 (30)

4.9 (2.0–11.8)

p= 0.001154

   Long term residence in a TB endemic country a

98 (17)

15 (56)

5.7 (2.6–12.5)

p= 0.000021

   IVDU b

59 (11)

5 (19)

 

P= 0.110

≥1 risk factor

184 (34)

21 (78)

7.2 (2.9–18.2)

p= 0.000003

HIV status

    

Age at HIV diagnosis, median years (25th–75th quartile)

34 (28–41)

34 (29–40)

 

P = 0.11

Years with HIV diagnosis, median years (25th–75th quartile)

8.5 (4–14)

7 (4–11.0)

 

P = 0.10

AIDS diagnosed, no (%)

107 (20)

6 (22)

 

P = 0.18

HAART treatment, no (%)

416 (77)

19 (70)

 

P = 0.13

CD4 cell count, mean (± s.d.)

523 (± 273)

600 (± 274)

 

P = 0.17

   0–99 CD4 cells/μL, (%)

13 (2)

0 (0)

  

   100–199 CD4 cells/μL, (%)

35 (6)

1 (4)

  

   200–300 CD4 cells/μL, (%)

55 (10)

2 (7)

  

   >300 CD4 cells/μL,l

440 (81)

24 (89)

  

HIV RNA, no (%)

    

   <500 copies per ml

412 (76)

18 (67)

 

0.10

   500 – 50,000 copies per ml

79 (15)

8 (30)

  

   >50,000 copies per ml

52 (10)

1 (4)

  

Factors presumed to influence immune status

    

Diabetes, no. (%)

18 (3)

2 (7)

 

0.18

Alc. Abuse, no (%)

59 (11)

3 (11)

 

0.24

  1. aIncidence >25/100,000.
  2. bIntravenous drug user
  3. Differences between media n values were analysed using Mann-Withney test, and differences between proportions using Chi Square test